key: cord-0009380-lsxg0rrm
authors: Hui, David S
title: Super-spreading events of MERS-CoV infection
date: 2016-07-09
journal: Lancet
DOI: 10.1016/s0140-6736(16)30828-5
sha: 0b7da26ab585f0c6c2a4fc6139f278b8a1211575
doc_id: 9380
cord_uid: lsxg0rrm

nan

Middle East respiratory syndrome coronavirus (MERS-CoV) was fi rst identifi ed in September, 2012, from a 68-year-old man who had died of severe pneumonia and multiorgan failure in Saudi Arabia in June, 2012. 1 Since then, MERS-CoV infection has spread to 27 countries, including South Korea, where 186 cases had been confi rmed within 2 months following the return of a Korean businessman (Patient 1) who had visited four countries in the Middle East between April 18 and May 3, 2015. 2 This major outbreak in South Korea is characterised by fi ve super-spreading events in hospital settings, 3 of which two were related-one at Pyeongtaek St Mary's Hospital (Pyeongtaek; by Patient 1) 4 and one at Samsung Medical Center (Seoul; by Patient 14). 3 During Patient 1's stay at Pyeongtaek St Mary's Hospital on May 15-17, 2015, he had infected 36 patients, including Patient 14, who was staying on the same fl oor. 4 Both Patient 1 and Patient 14 had sought medical attention at diff erent health-care facilities before being treated at the Samsung Medical Center on May 17-20 (Patient 1) and May 27-29 (Patient 14), around day 7 of their illness when they were highly infectious. However, it was Patient 14 who had led to the major nosocomial outbreak at the Samsung Medical Center. 3 Patient 1 had initially presented to the emergency room on May 17, 2015, when the hospital was full; he was admitted and isolated immediately on May 18, 2015, after his travel history to the Middle East was ascertained by a medical offi cer, without causing any nosocomial outbreak. 4 In The Lancet, Sun Young Cho and colleagues 5 report results from their comprehensive retrospective investigation of the MERS-CoV super-spreading event at the Samsung Medical Center emergency room, including a review of closed-circuit security video footage and electronic medical records. This nosocomial outbreak was most intriguing, with 82 people (33 patients, eight health-care workers, and 41 visitors) being infected following exposure to Patient 14 on May 27-29 in the emergency room. Patients staying in the same zone as Patient 14 had the highest attack rate (20% [23 of 117 patients]), compared with 5% (three of 58) in those with brief exposure to Patient 14 at the registration area or the radiology suite of the emergency room, and 1% (four of 500) in other patients who stayed in diff erent zones. The median incubation period of patients who stayed in the same zone as Patient 14 was shorter than that in patients who stayed in diff erent zones (5 days [IQR 4-8] vs 11 days [6] [7] [8] [9] [10] [11] [12] ; p<0·0001). No cases were documented in patients and visitors who had visited the emergency room on May 29 and were exposed only to potentially contaminated environment without direct contact with Patient 14. 5 The data suggest that the location (and hence the timing) of exposure to Patient 14 was an important factor in determining the attack rate and incubation period.

Several other predisposing factors to this superspreading event included failure to implement strict isolation of patients and quarantine of contacts at the fi rst outbreak hospital (Pyeongtaek St Mary's Hospital), 3,4 poor communication and knowledge of patient movement between hospitals, overcrowding in the emergency room, inadequate ventilation with only three air changes per h, and limited availability of isolation rooms in the emergency room. 5 At least six air changes per h in existing hospital facilities are needed to reduce room contamination in the management of acute respiratory infections, whereas 12 air changes per h are recommended for new or renovated facilities, especially when managing patients receiving mechanical ventilation and during aerosol-generating procedures. 6 Failure in infection control and prevention in health-care facilities has resulted in large numbers of secondary cases of MERS-CoV infection involving Several clinical trials have shown that statins reduce myocardial infarction, strokes, revascularisation procedures, and deaths from cardiovascular causes, 1 with only a small excess in muscle pain or weakness. 2 On the basis of a retrospective analysis of a database, Zhang and colleagues 3 reported that about 20% of individuals taking a statin stopped because of suspected side-eff ects. Of these, 35% restarted statin treatment and more than 90% tolerated statins, 3 indicating that the reasons for stopping medications were unrelated to statins in most cases. This key point was omitted by two publications, 4,5 which stated that 20% of patients on statins had side-eff ects, and this fi nding was widely reported in the UK media. Studies without a randomised blinded comparator group cannot distinguish between symptoms that individuals naturally have versus those caused by the medication. Matthews and colleagues 6 investigated the impact of this media coverage on use of statins in UK primary care. They found that after the intense media coverage of the two papers, 4,5 discontinuation of statins increased immediately for primary and

health-care workers, existing patients, and visitors in Saudi Arabia 7, 8 and several other countries in the past few years. 5, 9, 10 Common risk factors include exposure to contaminated and overcrowded health-care facilities, poor compliance with appropriate personal protection equipment when assessing patients with febrile respiratory illness, application of potential aerosolgenerating procedures (eg, resuscitation, continuous positive airway pressure, nebulised drugs), and lack of proper isolation room facilities. 5, [7] [8] [9] [10] The customs of patients seeking care at diff erent health-care facilities (so-called doctor shopping), as in the cases of Patients 1 and 14, and having friends and family members to stay with patients as caregivers at already overcrowded health-care facilities are unique factors in South Korea. 11 Although no aerosol-generating procedures were performed (with the exception of Patient 14 receiving supplemental oxygen at 2-5 L per min during his stay at the emergency room), 5 the role of such procedures, environmental contamination, and asymptomatic carriers in disease transmission would require further investigation in future major nosocomial outbreaks of MERS-CoV infection. Good compliance with appropriate personal protection equipment by health-care workers when managing patients with suspected and confi rmed MERS-CoV infection, early diagnosis, prompt isolation of infected patients, and improvement of ventilation in health-care facilities are important measures to prevent nosocomial outbreaks. 12 

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea

Epidemiologic features of the fi rst MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital

MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study

Natural ventilation for infection control in healthcare settings. Geneva: World Health Organization

Hospital outbreak of Middle East respiratory syndrome coronavirus

MERS-CoV outbreak in Jeddah-a link to health care facilities

Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings

WHO recommends continuation of strong disease control measures to bring MERS-CoV outbreak in Republic of Korea to an end. News release

Infection control and MERS-CoV in health-care workers